How to Interpret Phase II Data for Everolimus Plus Bevacizumab in Renal Cell Carcinoma

被引:7
作者
Escudier, Bernard [1 ]
机构
[1] Inst Gustave Roussy, Villejuif, France
关键词
INTERFERON-ALPHA;
D O I
10.1200/JCO.2009.27.4951
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2125 / 2126
页数:2
相关论文
共 11 条
[1]  
[Anonymous], J CLIN ONCOL S
[2]  
Bukowski RM, 2007, J CLIN ONCOL, V25, P4536, DOI 10.1200/JCO.2007.11.5154
[3]   A pilot study of thalidomide in patients with progressive metastatic renal cell carcinoma [J].
Daliani, DD ;
Papandreou, CN ;
Thall, PF ;
Wang, XM ;
Perez, C ;
Oliva, R ;
Pagliaro, L ;
Amato, R .
CANCER, 2002, 95 (04) :758-765
[4]   Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial [J].
Escudier, Bernard ;
Pluzanska, Anna ;
Koralewski, Piotr ;
Ravaud, Alain ;
Bracarda, Sergio ;
Szczylik, Cezary ;
Chevreau, Christine ;
Filipek, Marek ;
Melichar, Bohuslav ;
Bajetta, Emilio ;
Gorbunova, Vera ;
Bay, Jacques-Olivier ;
Bodrogi, Istvan ;
Jagiello-Gruszfeld, Agnieszka ;
Moore, Nicola .
LANCET, 2007, 370 (9605) :2103-2111
[5]   Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib [J].
Hainsworth, JD ;
Sosman, JA ;
Spigel, DR ;
Edwards, DL ;
Baughman, C ;
Greco, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :7889-7896
[6]   Phase II Trial of Bevacizumab and Everolimus in Patients With Advanced Renal Cell Carcinoma [J].
Hainsworth, John D. ;
Spigel, David R. ;
Burris, Howard A., III ;
Waterhouse, David ;
Clark, Bobby L. ;
Whorf, Robert .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) :2131-2136
[7]  
Merchan JR, 2007, J CLIN ONCOL, V25
[8]  
MOTZER RJ, 2003, CANCER IN PRESS
[9]   Sunitinib versus interferon alfa in metastatic renal-cell carcinoma [J].
Motzer, Robert J. ;
Hutson, Thomas E. ;
Tomczak, Piotr ;
Michaelson, M. Dror ;
Bukowski, Ronald M. ;
Rixe, Olivier ;
Oudard, Stephane ;
Negrier, Sylvie ;
Szczylik, Cezary ;
Kim, Sindy T. ;
Chen, Isan ;
Bycott, Paul W. ;
Baum, Charles M. ;
Figlin, Robert A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :115-124
[10]   Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206 [J].
Rini, Brian I. ;
Halabi, Susan ;
Rosenberg, Jonathan E. ;
Stadler, Walter M. ;
Vaena, Daniel A. ;
Ou, San-San ;
Archer, Laura ;
Atkins, James N. ;
Picus, Joel ;
Czaykowski, Piotr ;
Dutcher, Janice ;
Small, Eric J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (33) :5422-5428